fludarabine

01/01/2003 - "Fludarabine combined with cyclophosphamid is highly effective in the treatment of chronic lymphocytic leukemia."
10/08/1992 - "Patients with untreated B-cell chronic lymphocytic leukemia have a high rate of complete remission when given the halogenated nucleoside analogue fludarabine. "
01/01/2012 - "Fludarabine-based therapy is widely approved as a first-line treatment for chronic lymphocytic leukemia (CLL). "
03/01/2010 - "R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia."
07/01/2002 - "Fludarabine is a renally excreted agent that is an effective treatment for chronic lymphocytic leukemia (CLL), a disease predominantly of the elderly. "

11/01/1996 - "High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia."
07/01/2013 - "The second case, a 60-year-old woman with acute myelogenous leukemia, underwent allogeneic HSCT with the conditioning regimen consisting of ivBu (12.8 mg/kg) and fludarabine (150 mg/kg). "
07/01/2012 - "Sequential arabinosylcytosin with or without fludarabine in paracmastic patients with acute myeloid leukemia."
07/01/2010 - "Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients."
01/01/2004 - "Use of fludarabine in the treatment of acute myeloid leukemia."

09/01/2009 - "Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic?"
04/01/2004 - "Fludarabine-based regimen is highly effective for indolent lymphoma with mild toxicity. "
09/01/2004 - "In summary, fludarabine has proven to be a safe and effective agent in the treatment of indolent lymphoma. "
05/15/1990 - "Fludarabine is an important new agent effective against macroglobulinemic lymphoma, and should be evaluated further in combination with other active modalities."
07/01/1998 - "We report four patients with relapsed or refractory follicular (three) and lymphoplasmacytic (one) lymphoma who achieved complete remission (CR) with fludarabine (FDR) lasting from 3.2 to 6 years. "

09/01/2007 - "Fludarabine-containing regimens is well tolerated and effective in the treatment of low grade non-Hodgkin's lymphoma."
12/01/1999 - "Fludarabine is effective in chronic lymphocytic leukaemia (CLL) and low-grade non-Hodgkin's lymphoma (NHL). "
08/01/2002 - "Phase II study of fludarabine combined with interferon-alpha-2a followed by maintenance therapy with interferon-alpha-2a in patients with low-grade non-hodgkin's lymphoma."
06/01/1996 - "The aim of the study was to investigate the therapeutic activity of Fludarabine in patients with low-grade non-Hodgkin's lymphoma (LG-NHL) no longer responding to standard treatment. "
06/01/1996 - "Fludarabine: a phase II trial in patients with previously treated low-grade lymphoma."

02/01/2011 - "It is concluded that allo-HSCT by myeloablative conditioning regimen with fludarabine is a safe and effective option for high risk leukemia patients, which reduces aGVHD incidence and regimen-associated side effect, but it should be modified for higher rate of relapse."
09/01/2006 - "As a single agent, fludarabine has been effective for indolent leukemia. "
07/01/2005 - "Their leukemias responded well to therapy with fludarabine with initial treatment as well as relapse. "
04/01/1994 - "Eleven patients with relapsed CLL received autologous BMT with marrow collected during a prior fludarabine-induced remission; leukemia cells were depleted from the autologous marrow in seven patients using an anti-CD19 monoclonal antibody and immunomagnetic separation. "
03/01/1989 - "Fludarabine shows promise for some leukemia patients."